Can I use an electronic signature?

Yes. Electronic signatures are legally enforceable under the ESIGN Act (15 U.S.C. ch. 96) and UETA in most states, provided intent, consent, attribution, and retention requirements are met.

When is notarization required?

Notarization is not universally required for disclosures; check state law and the recipient's requirements. Some jurisdictions require notarization or witnesses for specific forms.

What about HIPAA-protected information?

If the disclosure contains protected health information, ensure HIPAA compliance and execute a BAA with the e-sign vendor where applicable.

Does a digital signature provide extra assurance?

A PKI-based digital signature provides cryptographic non-repudiation beyond a standard e-sign audit trail and may be required for certain regulated records.

How long must I retain signed disclosures?

Follow retention rules: IRS records 3 years (IRC §6501(a)); HIPAA six years (45 CFR §164.530(j)); industry-specific rules may be longer.

What if the signer disputes the signature?

Preserve the audit trail, authentication logs, and supporting evidence; these records are primary defenses to signature disputes in ESIGN/UETA contexts.

Electronic Signature
Templates
Finance
Financial Investment Disclosure

Financial Investment Disclosure

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

FINANCIAL INVESTMENT DISCLOSURE

Parties and Contact Information

Investor Name: Investor Address:

Investor Phone:

Investor Email:

Issuer / Adviser Name: Issuer / Adviser Contact:

Investment Summary

Principal Amount: $ Proposed Investment Date:

Investment Vehicle / Product Description:

Expected Term / Liquidity Window: Target Return:

Fees, Expenses and Compensation

Management Fee: Performance Fee:

Other Fees, Expenses or Charges (detail):

Risks and Disclosures

The undersigned acknowledges that the investment described above involves substantial risks, including but not limited to market risk, liquidity risk, counterparty risk, possible loss of principal, and tax treatment uncertainty. Past performance is not indicative of future results. The Issuer/Adviser has provided a written statement of material risk factors applicable to this investment; the Investor affirms receipt of such statement where indicated below.

I acknowledge receipt of the material risk factors statement.

I understand that I may lose some or all of my investment, and I accept the risk of such loss.

Suitability, Accreditation and Source of Funds

Investor Type: Individual Corporation / Entity Trust / Fiduciary

Accreditation Status: Accredited Not Accredited / Unsure

Source of Funds (brief description):

Conflicts of Interest and Related Parties

The Issuer/Adviser discloses that certain principals or affiliates may have positions or interests that create potential conflicts. The Issuer/Adviser will not be required to refrain from such transactions but will seek to manage conflicts in accordance with its policies and fiduciary duties.

Describe any known related-party relationships or holdings (if none, state "None"):

Reporting, Recordkeeping and Tax Treatment

The Issuer/Adviser will provide periodic account statements and tax reporting as required by applicable law. The Investor is solely responsible for the tax consequences of the investment and should consult a tax advisor. The Issuer/Adviser makes no guarantee as to tax treatment or reporting outcomes.

I acknowledge responsibility for all tax reporting and liabilities arising from this investment.

Representations, Warranties and Certifications

By signing below, the Investor represents, warrants and certifies to the Issuer/Adviser that:

The Investor is of legal age and has full power and authority to enter into this disclosure and any related agreements.

All information provided to the Issuer/Adviser regarding the Investor's financial condition and accreditation status is true, complete and current.

If any representation does not apply, explain here:

Consent to Electronic Delivery and Communication

The Investor consents to receive disclosures, notices and account statements electronically where permitted. The Investor may withdraw consent for electronic delivery as provided by the Issuer/Adviser in writing.

I consent to electronic delivery of statements and disclosures.

Acknowledgment and Signature

The undersigned Investor acknowledges receipt of this Financial Investment Disclosure, confirms that all information provided is accurate to the best of the Investor's knowledge, and accepts the risks, fees and terms described herein. This disclosure does not constitute an offer or guarantee of investment performance, and the Issuer/Adviser retains discretion to accept or decline participation.

Printed Name:

Signature:

Date:

Capacity / Title (if signing for an entity):

What the Financial Investment Disclosure Is

A Financial Investment Disclosure is a formal written statement that identifies an individual's or entity's financial interests, investment positions, conflicts, and relevant relationships that may affect investment advice, fiduciary duties, or transaction transparency. It explains sources of compensation, ownership stakes, referral arrangements, and any material conflicts that recipients need to evaluate. The document is used by broker-dealers, registered advisers, compliance teams, and counterparties to assess potential bias, ensure regulatory compliance, and create a record for audits and dispute resolution.

Why a Clear Financial Investment Disclosure Matters

A well-prepared disclosure reduces legal and compliance risk, supports informed decision-making, and documents potential conflicts. It helps meet regulatory expectations, builds traceable records for audits, and clarifies obligations between parties without replacing legal advice.

Who Typically Completes This Disclosure

Common preparers include financial advisors, investment managers, compliance officers, and corporate officers who must document material financial interests.

Registered Investment Advisers and compliance teams that must disclose adviser conflicts and compensation structures to clients.
Broker-dealers and registered reps disclosing ownership, referral fees, or outside business activities tied to transactions.
Individual investors or principals providing transparency for related-party transactions or private placement participation.

The recipient list often includes clients, counterparties, compliance departments, and counsel for transparency and recordkeeping.

Core Components of a Professional Disclosure

A complete disclosure combines identity details, precise financial interests, conflict descriptions, mitigation steps, relevant dates, and signature blocks for accountability.

Identity

Full legal name and entity type, registration numbers (CRD, SEC), and contact information so reviewers can verify the reporting party.

Holdings

List securities, private placements, derivatives, or beneficial ownership interests with dates and approximate percentage ownership where material.

Compensation

Detail fees, commissions, referral payments, revenue-sharing, and any contingent arrangements that could influence advice or transactions.

Conflicts

Explain the nature of each conflict, affected transactions, and whether the conflict is direct, indirect, or potential.

Mitigation

Describe steps taken to manage or mitigate conflicts such as disclosures to clients, recusal, third-party valuations, or supervisory oversight.

Certification

Signature, printed name, title, and effective date certifying the accuracy of the disclosure and establishing an auditable record.

Stepwise Completion and Submission Process

Follow these steps to assemble, validate, and submit a Financial Investment Disclosure in order.

01

Assemble Records: Collect investment statements, agreements, and compensation records supporting each disclosure item.
02

Populate Fields: Complete required fields carefully, following the fillable-fields instructions above.
03

Review Internally: Have compliance or counsel review for materiality, mitigating language, and completeness.
04

Sign and Archive: Execute signatures, date, and store with retention controls; distribute to required recipients.

Typical Digital Workflow for eSubmission

A standard eSubmission workflow reduces turnaround and creates an auditable trail for each disclosure.

Upload Document: Sender uploads the disclosure template or completed PDF to the e-sign platform.
Add Fields: Place signature, date, and required data fields; enable conditional fields if needed.
Authenticate Signer: Choose signer authentication (email, SMS code, KBA, or stronger) appropriate to the risk level.
Complete and Record: Signer executes; platform records IP, timestamp, and stores the audit trail with the final PDF.

Configuring an Electronic Workflow for This Disclosure

Configure fields, signer order, authentication, and retention before sending to ensure regulatory and audit readiness.

Field	Configuration
Signature Block	Require typed signature, full name, and date field; enable signer attestation checkbox.
Authentication	Use email link for low-risk; SMS code or KBA for higher-risk disclosures.
Signer Order	Set role-based signing sequence for adviser, compliance reviewer, then client.
Retention	Enable automatic archive with tamper-evident PDF and exportable audit trail.

Technical and Compliance Considerations for eSubmission

Choose a platform that supports compliance features, strong encryption, and exportable audit trails.

File Formats: Support for PDF and DOCX is essential; final signed records should be exportable as PDF/A for archival.
Integrations: Look for connectors to CRM, document management, and accounting systems to streamline distribution and storage.
Authentication: Platform should offer email, SMS, KBA, and SSO options to match the disclosure's risk profile.

Security and Compliance Features to Expect

Encryption: TLS 1.2/1.3 in transit; AES-256 at rest

Audit Trail: Comprehensive timestamped event log

Access Controls: Role-based permissions and SSO

Regulatory Certifications: SOC 2 Type II and ISO 27001

HIPAA Support: BAA available for protected health information

21 CFR Part 11: Compliance options for FDA-regulated records

Legal Risks and Potential Penalties

Misstatement Penalty: Civil or regulatory fines possible

1099 Reporting: Failing to report may trigger IRC §6721 penalties

I-9 Violations: Paperwork fines $281–$2,789 per violation

Intentional Disregard: Higher IRC penalties without cap

Breach of Fiduciary Duty: Contract liability and damages exposure

Privacy Violations: HIPAA breaches carry civil penalties

Common Preparation Errors to Avoid

Entering a nickname, abbreviation, or DBA instead of the full legal name which prevents reliable identity verification and triggers compliance review.
Omitting dates or using inconsistent date formats across related documents, which can create ambiguity about effective obligations and retention triggers.
Vague compensation descriptions that say 'market rate' or 'reasonable' instead of specifying dollar amounts or percentages, undermining auditability.
Failing to attach supporting statements or brokerage records that substantiate holdings and valuations, increasing dispute and verification time.

Timing Considerations and Reporting Deadlines

Certain filings and attachments trigger specific deadlines; meeting these dates reduces penalty risk and preserves statutory defenses.

Provide on Request:

W-9 information and similar disclosures must be furnished when requested by a payor.

1099-NEC Deadline:

File recipient and IRS copies by Jan 31 for nonemployee compensation.

Form 1040 Individual:

Annual individual tax filing due Apr 15; extensions available with Form 4868.

Record Retention Start:

Effective date of disclosure often establishes retention schedules.

Audit Availability:

Ensure signed records and audit trails are accessible for at least the minimum regulatory retention period.

Key Processing Milestones for the Disclosure

Track these milestones from preparation to archival to ensure compliance and timely distribution.

01

Draft Completion

All fields completed and initial supporting evidence attached.

02

Compliance Review

Internal reviewer confirms materiality analysis and mitigation measures.

03

Execution

Signatures obtained electronically or in-person; dates recorded.

04

Archival

Signed record and audit trail stored under retention controls.

How This Disclosure Compares With Similar Documents

Compare core differences between a Financial Investment Disclosure and a Conflict of Interest Disclosure to select the appropriate form.

Criteria	Financial Investment Disclosure	Conflict of Interest Disclosure
Typical Purpose	detail investments and compensation	disclose non-financial conflicts or relationships
eSignature Friendly
Regulatory Focus	securities and tax reporting	corporate governance and ethics
Supporting Docs	account statements, contracts	relationship letters, engagement terms

eSignature Pricing and Feature Snapshot for Disclosure Workflows

Compare starting prices and core capabilities of popular e-signature providers relevant to Financial Investment Disclosure workflows.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	Yes, 7-day free trial	No	No	Yes, limited	Yes, limited
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Real-World Examples of Disclosures in Use

These condensed case narratives illustrate how organizations implement disclosures and document controls.

Optica Ventures

A small investment firm standardized its disclosure template to include compensation and holdings

Used an audit trail to validate sign-off in 100% of client engagements
After centralizing records, the firm reduced review time and improved transparency with counterparties and auditors.

Fertility Centers of Illinois

A healthcare provider added disclosure language for physician investments in clinical trials

Implemented a BAA and limited PHI exposure during processing
The updated disclosure aligned internal compliance reviews with HIPAA retention and audit requirements.

Typical Signatories and Their Roles

Portfolio Manager

A portfolio manager prepares the disclosure to record personal holdings and outside business activities; accuracy is critical for compliance and supervisory review, and the manager typically certifies the statement under internal policy.

Compliance Officer

The compliance officer reviews disclosures for material conflicts, ensures mitigation steps are documented, and retains the signed record to satisfy audit requirements and regulatory examinations.

Practical Tips for Accurate and Efficient Disclosures

Apply consistent templates, strong identity checks, and clear supporting evidence to reduce review cycles and regulatory scrutiny.

Standardize Templates

Use a single approved template that includes mandatory fields and guidance, which reduces omissions and speeds review.

Attach Evidence

Include account statements or contract excerpts to substantiate holdings and compensation entries for faster verification.

Use Strong Authentication

For high-risk disclosures, require SMS codes, KBA, or SSO to strengthen signer attribution and reduce repudiation risk.

Maintain Audit Trail

Preserve the signed PDF and event log with retention controls to support audits and regulatory requests.

Frequently Asked Questions and Troubleshooting

Answers to common questions about completing, signing, and storing a Financial Investment Disclosure.

Need help? Contact support

Can I use an electronic signature?
Yes. Electronic signatures are legally enforceable under the ESIGN Act (15 U.S.C. ch. 96) and UETA in most states, provided intent, consent, attribution, and retention requirements are met.
When is notarization required?
Notarization is not universally required for disclosures; check state law and the recipient's requirements. Some jurisdictions require notarization or witnesses for specific forms.
What about HIPAA-protected information?
If the disclosure contains protected health information, ensure HIPAA compliance and execute a BAA with the e-sign vendor where applicable.
Does a digital signature provide extra assurance?
A PKI-based digital signature provides cryptographic non-repudiation beyond a standard e-sign audit trail and may be required for certain regulated records.
How long must I retain signed disclosures?
Follow retention rules: IRS records 3 years (IRC §6501(a)); HIPAA six years (45 CFR §164.530(j)); industry-specific rules may be longer.
What if the signer disputes the signature?
Preserve the audit trail, authentication logs, and supporting evidence; these records are primary defenses to signature disputes in ESIGN/UETA contexts.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now